UK markets close in 1 hour 15 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
141.31+0.76 (+0.54%)
As of 10:14AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
251,100
262,900
340,800
187,100
-
Other short-term investments
780,500
726,400
370,500
613,900
-
Total cash
1,031,600
989,300
711,300
801,000
-
Net receivables
439,300
350,000
185,500
157,100
-
Inventory
38,300
35,100
30,500
28,000
-
Other current assets
97,800
79,100
45,500
30,100
-
Total current assets
1,607,000
1,453,500
972,800
1,016,200
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
430,300
211,900
207,700
169,100
-
Accumulated depreciation
-83,000
-66,300
-51,900
-41,700
-
Net property, plant and equipment
347,300
145,600
155,800
127,400
-
Equity and other investments
849,400
401,500
624,400
265,300
-
Intangible assets
35,500
37,200
-
-
-
Other long-term assets
49,600
25,000
4,400
6,400
-
Total non-current assets
1,644,400
915,200
1,099,700
718,500
-
Total assets
3,251,400
2,368,700
2,072,500
1,734,700
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
170,100
169,400
-
-
408,800
Accounts payable
108,900
67,300
51,500
39,400
-
Taxes payable
24,400
9,000
-
-
-
Accrued liabilities
176,200
139,400
111,600
94,700
-
Other current liabilities
35,900
20,700
20,000
17,800
-
Total current liabilities
654,800
537,700
245,800
186,500
-
Non-current liabilities
Long-term debt
-
-
335,100
317,900
-
Other long-term liabilities
10,300
9,900
12,300
9,700
-
Total non-current liabilities
364,600
123,200
452,700
422,000
-
Total liabilities
1,019,400
660,900
698,500
608,500
-
Stockholders' equity
Common stock
100
100
100
100
-
Retained earnings
-157,100
-406,800
-635,800
-725,400
-
Accumulated other comprehensive income
7,000
-7,900
-1,700
1,800
-
Total stockholders' equity
2,232,000
1,707,800
1,374,000
1,126,200
-
Total liabilities and stockholders' equity
3,251,400
2,368,700
2,072,500
1,734,700
-